Table 2.
Enzyme | Inhibitor | IC50 (µM) |
k2 (M−1S−1) |
Type Inhibition | Culture IC50 (µM) |
Reference |
---|---|---|---|---|---|---|
PfGluPho | C276-1187 | 127 | ND | G6P: NC; NADP+ : NC | ND | [37,104] |
CB22 | 4.6 | ND | G6P: NC; NADP+ : NC | ND | [107] | |
CB61 | 5.1 | ND | G6P: MT; NADP+ : NC | ND | [107] | |
CB62 | 11.6 | ND | ND | ND | [107] | |
CB63 | 1.7 | ND | G6P: M; NADP+ : NC | ND | [107] | |
CB64 | 19.9 | ND | ND | ND | [107] | |
CB70 | 4.5 | ND | G6P: MT; NADP+ : NC | ND | [107] | |
CB103 | 1.1 | ND | G6P: MT; NADP+ : NC | ND | [107] | |
CB104 | 7.6 | ND | G6P: MT; NADP+ : NC | ND | [108] | |
ML276 | 0.889 | ND | ND | 2.6 | [108] | |
ML304 | 0.190 | ND | G6P: C; NADP+ : MT | 0.190 | [111] | |
Ellagic acid | 0.076 | ND | G6P: MT; NADP+ : MT | 0.105 | [110] | |
21 (vz0527) | 1.72 | ND | ND | ND | [109] | |
4 (vz1732) | 0.9 | ND | G6P: NC; NADP+ : NC | ND | [109] | |
SBI-0797750 | 0.0067 | ND | G6P: C; NADP+ : MT | 0.073 | [112] | |
PvGluPho | Ellagic acid | 0.032 | ND | G6P: MT; NADP+ : MT | ND | [109] |
ML304 | 15.3 | ND | G6P: C; NADP+ : MT | ND | [109] | |
21 (vz0527) | 0.2 | ND | ND | ND | [109] | |
4 (vz1732) | 0.2 | ND | ND | ND | [109] | |
SBI-0797750 | 31 | ND | G6P: MT; NADP+ : MT | ND | [112] | |
GlG6PD::6PGL | H-BZM-2 | 37 | 2.3 | ND | 36 | [113] |
O2N-BZM-7 | 12 | 1.92 | ND | 14 | [113] | |
O2N-BZM-9 | 20 | 6.13 | ND | 17 | [113] | |
CNZ-7 | 150 | 0.97 | ND | 8.7 | [114] | |
CNZ-8 | 80 | 0.60 | ND | 15 | [114] | |
CMC-1 | 70 | 1.88 | ND | 15 | [114] | |
FLP-2 | 256 | 0.82 | ND | 24.1 | [114] | |
TvG6PD::6PGL | O2N-BZM-7 | 22 | 0.8 | ND | 6 | [113] |
O2N-BZM-9 | 240 | 1.6 | ND | 4 | [113] | |
CNZ-3 | 93 | 0.66 | G6P: NC; NADP+ : C | ND | [115] | |
CNZ-17 | 356 | 0.38 | G6P: UC; NADP+ : UC | ND | [115] | |
JMM-3 | 155 | 0.33 | G6P: UC; NADP+ : UC | ND | [115] | |
MCC-7 | 260 | 0.26 | G6P: NC; NADP+ : UC | ND | [115] |
ND: Non determinate. C: Competitive-type inhibition. MT: Mixed-type inhibition. NC: Noncompetitive-type inhibition. UC: Uncompetitive-type inhibition.